Calidi Biotherapeutics(CLDI)
$0.51-0.02 (-4.17%)
CLDI
Calidi Biotherapeutics earnings date
$0.51
At close:-0.02 (-4.17%)
Want to see CLDI full AI Analyst Report?
Calidi Biotherapeutics (CLDI) Q2 2024 Earnings Report
375 Followers
CLDI Q2 2024 EPS Results
- Actual EPS
- -$268.80
- Consensus EPS
- -$278.40
- Beat/Miss
- Beat by +$9.60
- One Year Ago EPS
- -$1,747.20
CLDI Q2 2024 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- $0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/13/2024
- Time
- After Close
- Conference Call
- Tuesday, August 13, 2024
CLDI Upcoming Earnings
Calidi Biotherapeutics's next earnings date is estimated for March 12, 2027, based on past reporting schedules.
Q2 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
CLDI Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 12, 2027 | 2026 (Q4) | ―- | -9.12 | ― | ― |
| Nov 13, 2026 | 2026 (Q3) | ―-1.47 | -35.36 | 95.84% (+33.89) | |
| Aug 13, 2026 | 2026 (Q2) | ―-2.94 | -31.84 | 90.77% (+28.90) | |
| May 14, 2026 | 2026 (Q1) | ―-6.88 | -34.56 | 80.09% (+27.68) | |
| Mar 27, 2026 | 2025 (Q4) | ―-9.12 | -51.84 | 82.41% (+42.72) | |
| Nov 13, 2025 | 2025 (Q3) | -26.88-35.36 | -124.8 | 71.67% (+89.44) | |
| Aug 08, 2025 | 2025 (Q2) | -30.72-31.84 | -268.8 | 88.15% (+236.96) | |
| May 14, 2025 | 2025 (Q1) | ―-0.18 | -384 | 99.95% (+383.82) | |
| Mar 31, 2025 | 2024 (Q4) | -28.80-34.56 | -384 | 91.00% (+349.44) | |
| Nov 12, 2024 | 2024 (Q3) | -164.26-124.80 | -268.8 | 53.57% (+144.00) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

